ES2114722T3 - Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos. - Google Patents

Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.

Info

Publication number
ES2114722T3
ES2114722T3 ES95306053T ES95306053T ES2114722T3 ES 2114722 T3 ES2114722 T3 ES 2114722T3 ES 95306053 T ES95306053 T ES 95306053T ES 95306053 T ES95306053 T ES 95306053T ES 2114722 T3 ES2114722 T3 ES 2114722T3
Authority
ES
Spain
Prior art keywords
compound
formula
product
chem
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95306053T
Other languages
English (en)
Inventor
Douglas Patton Kjell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2114722T3 publication Critical patent/ES2114722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SUMINISTRA UN NUEVO PROCESO PARA PREPARAR UN COMPUESTO DE LA FORMULA (I) EN LA QUE R ES ALQUILO C{SUB, 1-4}; R1 Y R2 SON CADA UNA INDEPENDIENTEMENTE ALQUILO C{SUB, 1-4}, O SE COMBINAN PARA FORMAR PIPERIDINILO, PIRROLIDINILO, METILPIRROLIDINO, DIMETILPIRROLIDINO, MORFOLINO, DIMETILAMINO, DIETILAMINO, O 1-HEXAMETILENOIMINO; Y N ES 2 O 3; TAMBIEN SE PRESENTAN UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL COMPUESTO. EL PRODUCTO DEL PROCESO, UN COMPUESTO DE LA FORMULA (I), ES TAMBIEN NUEVO Y ES UTIL PARA LA PREPARACION DE COMPUESTOS FARMACOLOGICAMENTE ACTIVOS DE LA FORMULA (II), PARTICULARMENTE POR MEDIO DEL PROCESO PRESENTADO.
ES95306053T 1994-08-31 1995-08-30 Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos. Expired - Lifetime ES2114722T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,891 US5731436A (en) 1994-08-31 1994-08-31 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Publications (1)

Publication Number Publication Date
ES2114722T3 true ES2114722T3 (es) 1998-06-01

Family

ID=23152424

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95306053T Expired - Lifetime ES2114722T3 (es) 1994-08-31 1995-08-30 Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.

Country Status (15)

Country Link
US (2) US5731436A (es)
EP (1) EP0699673B1 (es)
JP (1) JPH08119912A (es)
KR (1) KR960007544A (es)
AT (1) ATE165356T1 (es)
BR (1) BR9503847A (es)
CA (1) CA2157235A1 (es)
DE (1) DE69502153T2 (es)
DK (1) DK0699673T3 (es)
ES (1) ES2114722T3 (es)
FI (1) FI954068A (es)
GR (1) GR3026743T3 (es)
HU (1) HUT73136A (es)
IL (3) IL115091A (es)
TW (1) TW368497B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
CA2213810C (en) * 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
US5948796A (en) * 1996-10-10 1999-09-07 Eli Lilly And Company Benzo B!thiophene compounds, intermediates, formulations, and methods
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US6017914A (en) * 1997-09-03 2000-01-25 Eli Lilly And Company Benzo[b]thiophene compounds, intermediates, formulations, and methods
FR2817865B1 (fr) * 2000-12-11 2005-02-18 Sanofi Synthelabo Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
EP1546138B1 (en) 2002-09-30 2012-01-18 A/S GEA Farmaceutisk Fabrik Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
JP5603019B2 (ja) * 2008-03-26 2014-10-08 帝人株式会社 植物由来成分を有するポリエステルおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864501A (en) * 1973-10-10 1975-02-04 Us Agriculture Method of enhancing coloration of fruits and vegetables with a dialhylamino-alkoxybenzene
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
KR970006890B1 (ko) * 1987-10-20 1997-04-30 오스카 세이야꾸 가부시끼가이샤 페닐카르복시산 유도체 및 그 염
JPH02101048A (ja) * 1988-10-07 1990-04-12 Fuji Photo Film Co Ltd サリチル酸誘導体の製造方法
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
US5731436A (en) 1998-03-24
GR3026743T3 (en) 1998-07-31
IL115091A0 (en) 1995-12-08
JPH08119912A (ja) 1996-05-14
EP0699673A1 (en) 1996-03-06
FI954068A0 (fi) 1995-08-30
FI954068A (fi) 1996-03-01
IL115091A (en) 2000-08-31
DE69502153T2 (de) 1998-09-17
TW368497B (en) 1999-09-01
US5955608A (en) 1999-09-21
IL126593A (en) 2000-08-31
ATE165356T1 (de) 1998-05-15
KR960007544A (ko) 1996-03-22
HU9502539D0 (en) 1995-10-30
EP0699673B1 (en) 1998-04-22
DK0699673T3 (da) 1998-10-07
CA2157235A1 (en) 1996-03-01
HUT73136A (en) 1996-06-28
DE69502153D1 (de) 1998-05-28
IL126593A0 (en) 1999-08-17
BR9503847A (pt) 1996-09-17

Similar Documents

Publication Publication Date Title
ES2114722T3 (es) Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.
FI76783C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 2-aminoalkoxi-1,7,7-trimetylbicyklo /2.2.1/heptanderivat.
ES2114721T3 (es) Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.
HU209788B (en) Process for preparing n-alkyl-carbamides
HU209723B (en) Process for producing of piperazine derivatives
US4095022A (en) Production of bis-(morpholino-n-alkyl) ethers
US4134889A (en) Manufacture of glycinonitriles
HU219493B (hu) Alkil-trazodon-származékok előállítására alkalmazható piperazinszármazékok és eljárás előállításukra
US5118682A (en) P-hydroxy phenone derivatives and the use thereof
IL22567A (en) New thiepin and oxepin derivatives and a process for their production
FI92482C (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-(3-hydroksifenyyli)-1-propanoniyhdisteiden aminopropanolijohdannaisten valmistamiseksi
GB2135994A (en) Process for the preparation of basic oxime ethers
DK166497B1 (da) Ammoniumsalte afledt af hexahydrodibenzooeb,eaaoe1,4aadioxin samt mellemprodukter
US3160656A (en) Benzocycloheptenones and derivatives
US5922874A (en) Process for preparing N-aryl-N'-alkyl-piperazines
NO167974B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater av 3-(2-hydroksyfenyl)-1-propanonforbindelser.
CA2011047A1 (en) Local anaesthetic compounds and a process for their preparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699673

Country of ref document: ES